Insider · CIK 0001999358
David McErlane
Files at CTLT (Catalent, Inc.). First filing -, latest -.
David McErlane files SEC Form 4 as president at CTLT (Catalent, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; David McErlane has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 18, 2024 | CTLT Catalent, Inc. | DDisposition to issuer Common Stock | -36,304 | - | - | 0 | Dec 18, 2024 |
| Dec 18, 2024 | CTLT Catalent, Inc. | AGrant or award Common Stock | +11,426 | $0.00 | $0 | 11,426 | Dec 18, 2024 |
| Dec 18, 2024 | CTLT Catalent, Inc. | DDisposition to issuer Common Stock | -11,426 | - | - | 0 | Dec 18, 2024 |
| Dec 18, 2024 | CTLT Catalent, Inc. | DDisposition to issuer Option to purchase Common Stockderivative | -14,740 | - | - | 0 | Dec 18, 2024 |
Questions about David McErlane
Answered from the filings on this page, as of the latest one.
Is David McErlane buying or selling?
David McErlane has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did David McErlane's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and David McErlane has 0.
Where does David McErlane file Form 4?
David McErlane has filed Form 4 at CTLT (Catalent, Inc.) as Group President, Biologics. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.